Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safety

Added 51 days ago (10.05.2022)
Authors: Frank Heldmann; Xenofon Baraliakos; Uta Kiltz; Jan Brandt; Irene E van der Horst-Bruinsma; Robert Landewé; Joachim Sieper; Gerd Rüdiger Burmester; Filip van den Bosch; Kurt de Vlam; Hill Gaston; Mathias Gruenke; Matthias Witt; Thierry Appelboom; Paul Emery; Maxime Dougados; Marjatta Leirisalo-Repo; Maxime Breban; Juergen Braun
Read article